03/10/2025 3:33 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/07/2025 5:05 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 7:00 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 3:53 PM | Janux Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2025 3:55 PM | Janux Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025 3:41 PM | Janux Therapeutics (Subject) Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:24 AM | JANUS HENDERSON GROUP PLC (Filed by) Janux Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025 8:30 AM | Adage Capital Management, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025 7:00 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 7:00 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 3:11 PM | Campbell David Alan (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for JANX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/03/2025 7:00 PM | Janux Therapeutics (Issuer) McIver Zachariah (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2025 7:01 PM | Janux Therapeutics (Issuer) Winter Charles M. (Reporting)
| Form 3/A | |
01/03/2025 7:10 PM | Dobek Maria (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 7:10 PM | DiRaimondo Thomas (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 7:10 PM | Janux Therapeutics (Issuer) Robinson Byron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 7:10 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 7:10 PM | Janux Therapeutics (Issuer) Winter Charles M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 7:10 PM | Janux Therapeutics (Issuer) McIver Zachariah (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 7:00 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 9:00 AM | Campbell David Alan (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024 5:25 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 3:32 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2024 3:28 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
12/03/2024 7:00 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 4:10 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2024 7:00 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Janux Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024 4:58 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024 6:08 PM | CAPPS VICKIE L (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 6:09 PM | Gujrathi Sheila (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 3:23 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 3:07 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 4:05 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 4:02 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:24 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:30 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:17 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024 3:07 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024 6:30 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 3:46 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Crypto’s crashing…but we’re still profiting (Ad) Most traders are panicking right now.
Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess.
The news is screaming fear.
But while most traders watch their portfolios tank… my friend Joel and his team at The Crypto Code are doing the opposite. |
10/25/2024 4:28 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/25/2024 3:57 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 3:44 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 3:51 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 11:37 AM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |
10/24/2024 4:53 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024 4:04 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024 3:15 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2024 4:59 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 4:38 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 4:39 PM | Janux Therapeutics (Subject) Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
10/23/2024 4:07 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 3:36 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024 3:20 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2024 3:16 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/22/2024 3:17 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
10/21/2024 3:43 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 3:25 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 12:39 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 5:51 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2024 3:57 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 3:39 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 3:48 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024 4:06 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024 3:24 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024 3:18 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 5:14 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:35 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:28 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:25 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:17 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024 4:10 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 7:49 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 4:29 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 4:34 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 6:30 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 6:31 PM | DiRaimondo Thomas (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 6:32 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 5:31 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:05 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:51 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:51 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:54 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:18 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:01 PM | Janux Therapeutics (Subject) Meyer Andrew Hollman (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:05 PM | Campbell David Alan (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:57 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:35 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024 4:13 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 8:35 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
Lying in hospital… staring at the light (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune.
After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life |
09/16/2024 8:41 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024 4:01 PM | Janux Therapeutics (Subject) Lichter Jay (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 8:18 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 7:54 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 8:07 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 7:42 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 5:23 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:51 PM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |
09/11/2024 10:20 AM | Janux Therapeutics (Subject) Reardon Tighe (Reporting)
| Form 144/A | |